Ethyl 3-(N-butyl-4-methylbenzamido)propanoate, 97%, 1g

4,4-Dimethylisoxazolidin-3-one, 97%, 1g

4-(4-(3-(Pyridin-2-yl)-1H-pyrazol-4-yl)pyridin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)benzamide, 95%, 10mg

3,7-Dimethyloct-6-en-1-yl formate, 95.0%, 25g

4-(ANTHRACEN-9-YL)-3-(TERT-BUTYL)-2,3-DIHYDROBENZO[D][1,3]OXAPHOSPHOLE, 95%, 100mg

ETHYL 7-BROMO-3-(3-HYDROXYPROPYL)-1H-INDOLE-2-CARBOXYLATE, 95.0%, 250mg

3-(4-Chloro-phenyl)-1H-pyrazole-4-carbaldehyde, 95.0%, 250mg

1-(2-Bromobenzyl)pyrrolidine, 97.0%, 250mg

2-chloro-3'-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4-fluorobenzophenone, 97.0%, 1g

n-Octyl Acrylate (stabilized with MEHQ)>98.0%(GC)25mL

3-Formylbenzoic acid, 95.0%, 1g

3-Chloro-2-hydroxypyridine>98.0%(GC)1g

N-(cyanomethyl)-4-nitrobenzamide, 98%, 250mg